Wellgistics Health Inc WGRX Q1 2026 Earnings Narrowed Loss Fails to Lift Market Sentiment CYD Q3 2020 Earnings Near InLine EPS as China Recovery Supports Demand MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses Kenon Holdings Q2 2025 Earnings Positive EPS of 010 Amid Limited Disclosures